Victoza and Saxenda are both medications developed by Novo Nordisk, containing the active ingredient liraglutide
Kisspeptin Peptide: What the Human Evidence Shows Kisspeptin peptide sits upstream of GnRH and drives LH, FSH, and testosterone
Observations in murine models of GHRH gene ablation point to possible normalization of growth indicators, including body weight, bone length, and lean mass, with concurrent increases in pituitary RNA and GH mRNA levels
Given 2024 multi-society guidance, most patients can continue GLP-1s before elective procedures, but tell your team early
Lee: GLP-1 agonists primarily affect the gastrointestinal system, but they also act on the brain, particularly the hypothalamus, which regulates many core functions, including hormones, temperature, and appetite
Observation: The team ensures safety throughout the process